Stocks / ACHV
Stock profile · 銘柄

Achieve Life Sciences, Inc. - Common Shares (ACHV)

Achieve Life Sciences, Inc. - Common Shares (ACHV) last closed at $6.40 (as of 2026-07-02). On Shishin's four-engine momentum model it scored 36/100, flagged by the Suzaku engine on its most recent scan appearance (2026-07-02). It has surfaced in 1 daily scan since 2026-07-02. The figures below are research data, the composite score and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Price updates daily; the engine read reflects ACHV's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.

Composite score36
Active engineSuzaku
SetupOTHER
Current close$6.40
SectorBiotechnology
Price · last ~60 sessions
$6.403/64/177/2
Indicators · as of 2026-07-02
ADR · 20d8.7%
ATR · 147.3%
RSI · 1466
Return · 30d+34%
Return · 60d+98%
Above MA2015%
Above MA5026%
Range · 20d51%
MA stack3
From 52w high-10%
$ Vol · 30d$9M
Vol ratio2.35×
Frequently asked

What is ACHV's Shishin momentum score?

As of 2026-07-02, ACHV scores 36/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.

Is ACHV showing a momentum setup?

ACHV's current setup state is "OTHER." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.

Which Shishin engine flags ACHV?

Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.

How often has ACHV appeared in Shishin scans?

ACHV has appeared in 1 daily scan since 2026-07-02. Recurring appearances indicate a persistent setup; one-off appearances are more transient.

How is the Shishin score calculated?

The composite is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.

Related reading

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →5-year track record →More Biotechnology momentum stocks →More Suzaku setups →All covered stocks →